Caroline Lonez

Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression

Benjamin Le Calvé, Michał Rynkowski, Marie Le Mercier et al. · Neoplasia · 2010 · 133 citations · Full text

Vitro Treatment, Metabolic Remodeling, High-grade Gliomas +19

Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways

Caroline Lonez, Michel Bessodes, Daniel Scherman et al. · Nanomedicine Nanotechnology Biology and Medicine · 2013 · 122 citations

Inflammation, Toll-like Receptors, Nanomedicine +9

DiC14‐amidine cationic liposomes stimulate myeloid dendritic cells through Toll‐like receptor 4

Tetsuya Tanaka, Amandine Legat, Emmanuelle Adam et al. · European Journal of Immunology · 2008 · 96 citations

CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial

David A. Sallman, Tessa Kerre, Violaine Havelange et al. · The Lancet Haematology · 2023 · 83 citations · Full text

Hematological Malignancy, Cell Therapy, Dose Escalation Segment +11

NKG2D-based chimeric antigen receptor therapy induced remission in a relapsed/refractory acute myeloid leukemia patient

David A. Sallman, Jason Brayer, Elizabeth M. Sagatys et al. · Haematologica · 2018 · 76 citations · Full text

Hematological Malignancy, Cell Therapy, Malignant Blood Disorder +5